Abstract
Purpose
To provide a comprehensive update of the joint consultation of the International Consultation on Urological Diseases (ICUD) for the diagnosis and management of non-urothelial cancer of the urinary bladder.
Methods
A detailed analysis of the literature was conducted reporting on the epidemiology, etiology, diagnosis, treatment and outcomes of non-urothelial cancer of the urinary bladder. An international, multidisciplinary expert committee evaluated and graded the evidence according to the Oxford System of Evidence-based Medicine modified by the ICUD.
Results
The major non-urothelial cancers of the urinary bladder are squamous cell carcinoma, adenocarcinoma, and neuroendocrine tumors. Several other non-urothelial tumors are rare but important to identify because of their aggressive behavior when compared to urothelial bladder tumors. Radical cystectomy and urinary diversion, preceded by neoadjuvant radiation or chemotherapy in some of these tumors, is the main method or treatment for resectable disease. Adjuvant therapy is not usually successful and no novel targeted or immunotherapeutic agents have been identified to provide benefit. Patients with small cell neuroendocrine tumors of the bladder should be offered chemotherapy before surgery. Because non-urothelial cancers are usually locally advanced and/or metastatic at the time of diagnosis, 5-year survival is generally poor.
Conclusions
Non-urothelial cancers of the urinary bladder are rare and mostly lack established protocols for treatment. The prognosis of most of these tumors is poor because they are usually advanced at the time of diagnosis. A multimodal treatment approach should be considered to improve outcomes.
Similar content being viewed by others
References
Miller A, Mitchell JP, Brown NJ (1969) The Bristol Bladder Tumour Registry. Br J Urol 41(Suppl):1–64
Johnson DE, Schoenwald MB, Ayala AG, Miller LS (1976) Squamous cell carcinoma of the bladder. J Urol 115(5):542–544
Johansson SL, Cohen SM (1997) Epidemiology and etiology of bladder cancer. Semin Surg Oncol 13(5):291–298
Liang FX, Bosland MC, Huang H et al (2005) Cellular basis of urothelial squamous metaplasia: roles of lineage heterogeneity and cell replacement. J Cell Biol 171(5):835–844
Clouston D, Lawrentschuk N (2013) Metaplastic conditions of the bladder. BJU Int 112(Suppl 2):27–31
Kantor AF, Hartge P, Hoover RN, Fraumeni JF Jr (1988) Epidemiological characteristics of squamous cell carcinoma and adenocarcinoma of the bladder. Can Res 48(13):3853–3855
Blochin EB, Park KJ, Tickoo SK, Reuter VE, Al-Ahmadie H (2012) Urothelial carcinoma with prominent squamous differentiation in the setting of neurogenic bladder: role of human papillomavirus infection. Mod Pathol 25(11):1534–1542
Sheaff M, Jenkins BJ (1994) Squamous cell carcinoma of the bladder following radiotherapy for transitional cell carcinoma. Br J Urol 74(1):131–132
Stein JP, Skinner EC, Boyd SD, Skinner DG (1993) Squamous cell carcinoma of the bladder associated with cyclophosphamide therapy for Wegener’s granulomatosis: a report of 2 cases. J Urol 149(3):588–589
Rundle JS, Hart AJ, McGeorge A, Smith JS, Malcolm AJ, Smith PM (1982) Squamous cell carcinoma of bladder. A review of 114 patients. Br J Urol 54(5):522–526
Jones MA, Bloom HJ, Williams G, Trott PA, Wallace DM (1980) The management of squamous cell carcinoma of the bladder. Br J Urol 52(6):511–514
Debbagh A, Bennani S, Hafiani M, El Mrini M, Benjelloun S (1997) Epidermoid carcinoma of the bladder: apropos of 14 cases. Ann Urol (Paris) 31(4):199–203
Serretta V, Pomara G, Piazza F, Gange E (2000) Pure squamous cell carcinoma of the bladder in western countries. Report on 19 consecutive cases. Eur Urol 37(1):85–89
Quilty PM, Duncan W (1986) Radiotherapy for squamous carcinoma of the urinary bladder. Int J Radiat Oncol Biol Phys 12(6):861–865
Navon JD, Soliman H, Khonsari F, Ahlering T (1997) Screening cystoscopy and survival of spinal cord injured patients with squamous cell cancer of the bladder. J Urol 157(6):2109–2111
El-Boulkany MN, Ghoneim MA, Mansour MA (1972) Carcinoma of the bilharzial bladder in Egypt. Clinical and pathological features. Br J Urol. 44(5):561–570
Ghoneim MA, El-Mekresh MM, El-Baz MA, El-Attar IA, Ashamallah A (1997) Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases. J Urol. 158(2):393–399
Lopez JI, Angulo Cuesta J, Flores Corral N, Toledo JD (1994) Squamous cell carcinoma of the urinary bladder. Clinico-pathologic study of 7 cases. Arch Esp Urol 47(8):756–760
Ghoneim MA, Awaad HK (1980) Results of treatment in carcinoma of the bilharzial bladder. J Urol 123(6):850–852
Ghoneim MA, Ashamallah AG, El-Hammady S, Gaballah MA, Soliman el SH (1979) Cystectomy for carcinoma of the bilharzial bladder: 138 cases 5 years later. Br J Urol 51(6):541–544
Ghoneim MA, Ashamallah AK, Awaad HK, Whitmore WF Jr (1985) Randomized trial of cystectomy with or without preoperative radiotherapy for carcinoma of the bilharzial bladder. J Urol 134(2):266–268
El-Mawla NG, El-Bolkainy MN, Khaled HM (2001) Bladder cancer in Africa: update. Semin Oncol 28(2):174–178
Wu Y, Enting D, Rudman S, Chowdhury S (2015) Immunotherapy for urothelial cancer: from BCG to checkpoint inhibitors and beyond. Expert Rev Anticancer Ther 15(5):509–523
Wright JL, Porter MP, Li CI, Lange PH, Lin DW (2006) Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder. Cancer 107(4):721–728
Young RH, Scully RE (1985) Clear cell adenocarcinoma of the bladder and urethra. A report of three cases and review of the literature. Am J Surg Pathol 9(11):816–826
Zaffuto E, Gazdovich S, Leyh-Bannurah SR et al (2017) Contemporary rates of pathological features and mortality for adenocarcinoma of the urinary bladder in the USA. Int J Urol 24(2):117–123
Zaghloul MS, El Baradie M, Nouh MA, Abdel-Fatah S, Taher A, Shalaan M (2007) Prognostic index for primary adenocarcinoma of the urinary bladder. Gulf J Oncol. 2:47–54
Roy S, Pradhan D, Ernst WL et al (2017) Next-generation sequencing-based molecular characterization of primary urinary bladder adenocarcinoma. Mod Pathol 30(8):1133–1143
Ghoneim MA, Abdel-Latif M, el-Mekresh M et al (2008) Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later. J Urol 180(1):121–127
Smeulders N, Woodhouse CR (2001) Neoplasia in adult exstrophy patients. BJU Int 87(7):623–628
Nerli RB, Kamat GV, Alur SS, Koura A, Prabha V, Amarkhed SS (2008) Bladder exstrophy in adulthood. Indian J Urol. 24(2):164–168
Ko JS, Di Carlo HN, Gupta AD, Ross AE, Eckhauser FE, Bivalacqua TJ (2013) Adenocarcinoma of the ileal conduit in a patient born with classic bladder exstrophy. Urol Case Rep 1(1):5–6
Paulhac P, Maisonnette F, Bourg S, Dumas JP, Colombeau P (1999) Adenocarcinoma in the exstrophic bladder. Urology 54(4):744
Melicow MM (1955) Tumors of the urinary bladder: a clinico-pathological analysis of over 2500 specimens and biopsies. J Urol 74(4):498–521
Weinstein RP, Grob BM, Pachter EM, Soloway S, Fair WR (2001) Partial cystectomy during radical surgery for nonurological malignancy. J Urol 166(1):79–81
Gao F, Cao YF, Chen LS, Zhang S, Tang ZJ, Liang JL (2007) Outcome of surgical management of the bladder in advanced colorectal cancer. Int J Colorectal Dis 22(1):21–24
Blomjous CE, Vos W, De Voogt HJ, Van der Valk P, Meijer CJ (1989) Small cell carcinoma of the urinary bladder. A clinicopathologic, morphometric, immunohistochemical, and ultrastructural study of 18 cases. Cancer 64(6):1347–1357
Cramer SF, Aikawa M, Cebelin M (1981) Neurosecretory granules in small cell invasive carcinoma of the urinary bladder. Cancer 47(4):724–730
Zhao X, Flynn EA (2012) Small cell carcinoma of the urinary bladder: a rare, aggressive neuroendocrine malignancy. Arch Pathol Lab Med 136(11):1451–1459
Ou WT, Liang QL, Huang X, Li ZY, Liu QL (2015) Small cell carcinoma of the urinary bladder: a case report and review of the literature. Oncol Lett 9(1):488–490
Lynch SP, Shen Y, Kamat A et al (2013) Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic down staging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center. Eur Urol 64(2):307–313
Mattes MD, Kan CC, Dalbagni G, Zelefsky MJ, Kollmeier MA (2015) External beam radiation therapy for small cell carcinoma of the urinary bladder. Pract Radiat Oncol 5(1):e17–e22
Quek ML, Nichols PW, Yamzon J et al (2005) Radical cystectomy for primary neuroendocrine tumors of the bladder: the university of southern california experience. J Urol 174(1):93–96
Siefker-Radtke AO, Kamat AM, Grossman HB et al (2009) Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer. J Clin Oncol 27(16):2592–2597
Akamatsu S, Kanamaru S, Ishihara M, Sano T, Soeda A, Hashimoto K (2008) Primary large cell neuroendocrine carcinoma of the urinary bladder. Int J Urol 15(12):1080–1083
Chen YB, Epstein JI (2011) Primary carcinoid tumors of the urinary bladder and prostatic urethra: a clinicopathologic study of 6 cases. Am J Surg Pathol 35(3):442–446
Martignoni G, Eble JN (2003) Carcinoid tumors of the urinary bladder. Immunohistochemical study of 2 cases and review of the literature. Arch Pathol Lab Med 127(1):e22–e24
Kunz PL (2015) Carcinoid and neuroendocrine tumors: building on success. J Clin Oncol 33(16):1855–1863
Parekh DJ, Jung C, O’Conner J, Dutta S, Smith ER Jr (2002) Leiomyosarcoma in urinary bladder after cyclophosphamide therapy for retinoblastoma and review of bladder sarcomas. Urology 60(1):164
Lee TK, Miyamoto H, Osunkoya AO, Guo CC, Weiss SW, Epstein JI (2010) Smooth muscle neoplasms of the urinary bladder: a clinicopathologic study of 51 cases. Am J Surg Pathol 34(4):502–509
Russo P, Brady MS, Conlon K et al (1992) Adult urological sarcoma. J Urol. 147(4):1032–1036 (discussion 1036–1037)
Taylor RE, Busuttil A (1989) Case report: adult rhabdomyosarcoma of bladder, complete response to radiation therapy. J Urol 142(5):1321–1322
Nawar NA, Olsen J, Jelic TM, He C (2016) Primary urinary bladder angiosarcoma with osteoclast-like multinucleated giant cells: a case report and literature review. Am J Case Rep 17:143–149
Klingler HC, Klingler PJ, Martin JK Jr, Smallridge RC, Smith SL, Hinder RA (2001) Pheochromocytoma. Urology 57(6):1025–1032
Montgomery EA, Shuster DD, Burkart AL et al (2006) Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma. Am J Surg Pathol 30(12):1502–1512
Iczkowski KA, Shanks JH, Gadaleanu V et al (2001) Inflammatory pseudotumor and sarcoma of urinary bladder: differential diagnosis and outcome in thirty-eight spindle cell neoplasms. Mod Pathol 14(10):1043–1051
Patil RV, Woldu SL, Lucas E, Quinn AM, Francis F, Margulis V (2017) Metastatic melanoma to the bladder: case report and review of the literature. Urol Case Rep 11:33–36
Karabulut YY, Erdogan S, Sayar H, Ergen A, Ertoy Baydar D (2016) Primary malignant melanoma of the urinary bladder: clinical, morphological, and molecular analysis of five cases. Melanoma Res 26(6):616–624
Schniederjan SD, Osunkoya AO (2009) Lymphoid neoplasms of the urinary tract and male genital organs: a clinicopathological study of 40 cases. Mod Pathol 22(8):1057–1065
Al-Maghrabi J, Kamel-Reid S, Jewett M, Gospodarowicz M, Wells W, Banerjee D (2001) Primary low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type arising in the urinary bladder: report of 4 cases with molecular genetic analysis. Arch Pathol Lab Med 125(3):332–336
Kempton CL, Kurtin PJ, Inwards DJ, Wollan P, Bostwick DG (1997) Malignant lymphoma of the bladder: evidence from 36 cases that low-grade lymphoma of the MALT-type is the most common primary bladder lymphoma. Am J Surg Pathol 21(11):1324–1333
Author information
Authors and Affiliations
Contributions
SA: Data collection, manuscript writing. IA-C: Data collection, manuscript writing. PM: Data collection, manuscript writing. RK: Data collection, manuscript writing. KGN: Data collection, manuscript writing. GPP: Data collection, manuscript writing. MIP: Data collection, manuscript writing. MRR: Data collection, manuscript writing. AL-B: Project supervision, manuscript writing and editing. BRK: Project supervision, manuscript writing and editing.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest to disclose.
Ethical statement
I testify on behalf of all co-authors that our article submitted to World Journal of Urology has not been published in whole or in part elsewhere, is not currently being considered for publication in another journal, and that all authors have been personally and actively involved in substantive work leading to the manuscript, and will hold themselves jointly and individually responsible for its content.
Human or animal statement
This research does not involve human or animal subjects. This work is a review of the literature. No institutional review board was required because no active research was preformed.
Rights and permissions
About this article
Cite this article
Alanee, S., Alvarado-Cabrero, I., Murugan, P. et al. Update of the International Consultation on Urological Diseases on bladder cancer 2018: non-urothelial cancers of the urinary bladder. World J Urol 37, 107–114 (2019). https://doi.org/10.1007/s00345-018-2421-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-018-2421-5